A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy

<i>Background and Objectives:</i> Studies have shown a lower prevalence of anti-SARS-CoV-2 antibodies in patients with inflammatory bowel disease (IBD), including amongst those receiving biological therapy. Aims were to determine the seroprevalence of anti-SARS-CoV-2 antibodies in IBD patients and t...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mirko Di Ruscio, Gianluigi Lunardi, Dora Buonfrate, Federico Gobbi, Giulia Bertoli, Donatella Piccoli, Antonio Conti, Andrea Geccherle, Angela Variola
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2021-10-01
Colecção:	Medicina
Assuntos:	seroprevalence anti-SARS-CoV-2 antibodies inflammatory bowel disease COVID-19
Acesso em linha:	https://www.mdpi.com/1648-9144/57/10/1048
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!